US Stem Cell (USRM) Income Statement
US Stem Cell Income Statement
Last quarter (Q4 2022), US Stem Cell's total revenue was $19.97K, a decrease of 15.34% from the same quarter last year. In Q4, US Stem Cell's net income was $-566.62K. See US Stem Cell’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 |
|---|---|---|---|---|---|
| $ 82.05K | $ 200.75K | $ 277.09K | $ 3.07M | $ 6.70M | |
| $ 58.28K | $ 148.72K | $ 212.97K | $ 1.74M | $ 4.59M | |
| $ 1.78M | $ 2.28M | $ 2.61M | $ 5.15M | $ 5.69M | |
| Depreciation and Amortization | $ 0.00 | $ 2.14M | $ 242.62K | $ 242.62K | $ 207.13K |
| $ -2.17M | $ -151.41K | $ -2.16M | $ -2.61M | $ -508.49K | |
| $ -1.72M | $ -2.14M | $ -2.40M | $ -3.42M | $ -1.10M | |
| $ -1.14M | $ -1.15M | $ -490.25K | $ -418.48K | $ -1.06M | |
| $ -2.86M | $ -3.29M | $ -2.89M | $ -3.84M | $ -2.16M | |
| $ -2.86M | $ -3.29M | $ -2.89M | $ -3.84M | $ -2.16M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.00 | $ -0.01 | $ -0.01 | $ -0.01 | $ -0.01 |
| Diluted EPS | $ -0.00 | $ -0.01 | $ -0.01 | $ -0.01 | $ -0.01 |
| Weighted Average Shares Outstanding | 591.56M | 460.79M | 429.29M | 398.04M | 365.64M |
| Weighted Average Shares Outstanding (Diluted) | 591.56M | 460.79M | 429.29M | 398.04M | 365.64M |
Currency in USD
